glp 1 smoking cessation GLP-1s for Smokers: Quitting without Weight Gain GLP-1 Therapy: A Promising Approach

74 WangX.ThomasB.SachdevaR.ArterburnL.FryeL.HatcherP

Han T, Hu X, Li K, Zhang D, Zhang Y, Li J (2021) Bifidobacterium infantis maintains genome stability in ulcerative colitis via regulating anaphase-promoting complex subunit 7

Targeting Toll-like receptor-4 to tackle preterm birth and fetal inflammatory injury

Kojima K, Kornblau SM, Ruvolo V, Duvvuri S, Davis ER, Zhang M, Wang Z, Coombes KR, Zhang N, Qiu Y, Burks JK, Ruvolo P, Shacham S, Kauffman M, Andreeff M

Patients with established cardiovascular disease may benefit from specific GLP-1 therapies (semaglutide, dulaglutide, or liraglutide) that have demonstrated cardiovascular risk reduction in clinical trials, though these benefits are observed during active treatment

What has human clinical evidence: ARA-290 produced measurable nerve fiber regrowth in humans with small fiber neuropathy in placebo-controlled trials over 28 days